Head-to-head · WeighScore
Joey Med vs Zealthy
The verdict
Joey Med takes it — 53.9/100 to 46.7/100.
Joey Med grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Joey Med is a Tampa, FL telehealth platform offering injectable GLP-1 weight-loss treatments alongside sexual health, longevity, hair-growth, and travel-wellness products — a multi-vertical model for…
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Joey Med | Zealthy |
|---|---|---|
| WeighScore | 53.9/100 | 46.7/100 |
| Grade | C | C |
| Scorecard rank | #461 | #496 |
| Semaglutide | $279/mo (compounded) | $286/mo (starting dose, plus a separate fee, compounded) |
| Tirzepatide | $399/mo (compounded) | $351/mo (starting dose, plus a separate fee, compounded) |
| Coverage | All 50 states | 34 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #461 · C
Strengths
- Three GLP-1 tiers listed with dual pricing on the products page
- Ships to all 50 states
- Refund and cancellation policy publicly linked
- Tampa, FL location anchor provides a geographic identifier
- Lets patients consolidate weight loss with ED, hair, and longevity treatments
Where it loses points
- Drug names (semaglutide vs tirzepatide) not disclosed — products sold as 'GLP-1 Core / Plus / High Dose'
- Compounded vs brand-name not stated (appears compounded but unconfirmed)
- 503A vs 503B designation not specified
- Pharmacy partner not named
- No LegitScript certification mentioned
Graded #496 · C
Strengths
- Serves 34 states — meaningful nationwide footprint
- Asynchronous model removes friction for patients who don't want a video visit
- Independent licensed prescribers retain full clinical authority
Where it loses points
- Active Novo Nordisk false-advertising lawsuit alleging trademark infringement and marketing compounded drugs as FDA-approved alternatives
- Active DOJ/FTC enforcement alleging undisclosed subscription terms, locked cancellation, and unauthorized health-data sharing
- Founder previously ran Cerebral, which settled with the FTC in 2024 over similar deceptive practices
- Recently rebranded to Gronk Inc. amid active enforcement
- FDA issued this company a warning letter dated 1 September 2025; the letter is public in FDA's warning-letter database
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.